These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 114185)

  • 1. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino (1,2-a) quinoline (compound 69/183). Part I: Hypotensive activity.
    Singh GB; Srimal RC; Nityanand S; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1087-91. PubMed ID: 114185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino ]1,2-a] quinoline hydrochloride (compound 69/183). Part III: Assessment of tranquillising activity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(8):1403-6. PubMed ID: 37855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1-(H)-pyrazino(1,2-a)quinoline hydrochloride (compound 69/183). Part IV: other CNS effects and acute toxicity.
    Singh GB; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1978; 28(9):1641-4. PubMed ID: 582569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on 3-[gamma-(p-fluorobenzoyl)propyl]-2,3,4,4a,5,6-hexahydro-1 (H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69/183). Part II: Effect on cardiac dynamics.
    Srimal RC; Mason DF; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1092-5. PubMed ID: 582695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and central nervous system depressant properties of 3-(gamma-p-fluorobenzoyl propyl) 2,3,4,4a,5,6-hexahydro-1(H)-pyrazino(1,2-a) quinoline hydrochloride (compound 69-183, centpyraquin).
    Singh GB; Nityanand S; Srimal RC; Rao VA; Jain PC; Dhawan BN
    Experientia; 1973 Dec; 29(12):1529-30. PubMed ID: 4203916
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I; Lefèvre-Borg F; Gomeni R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of substance P and serotonin in the pyloric motor control. An experimental study in cat and rat.
    Lidberg P
    Acta Physiol Scand Suppl; 1985; 538():1-69. PubMed ID: 2418634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of canine adrenergic transmission by an analog of dopamine: GJH-166.
    Sharabi FM; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1977 Jul; 202(1):97-104. PubMed ID: 195039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglionic action of some newly synthesized glutarimide compounds.
    Patel NB; Jindal MN; Patel VK
    Arzneimittelforschung; 1978; 28(7):1071-5. PubMed ID: 582691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the mode of action of heptaminol (author's transl)].
    Grobecker H; Grobecker H
    Arzneimittelforschung; 1976; 26(12):2167-71. PubMed ID: 1037266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U-54,669F: a novel hypotensive agent.
    Wendling MG; DuCharme DW; Johnson GA; McCall RB; Pals DT
    Fed Proc; 1983 Feb; 42(2):162-6. PubMed ID: 6822289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiovascular and autonomic properties of N-phenylpiperazine (NPP) in several animal models.
    Cohen MR; Hinsch E; Palkoski Z; Vergona R; Urbano S; Sztokalo J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):110-9. PubMed ID: 6126578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.